Form 4: Beam Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christine Bellon, Chief Legal Officer of Beam Therapeutics, sold 3,401 shares of common stock on April 1, 2024, to cover tax withholding obligations.
Summary
- Christine Bellon, the Chief Legal Officer of Beam Therapeutics Inc. (BEAM), sold 3,401 shares of common stock on April 1, 2024.
- The sale was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were sold at a weighted average price of $32.12, with individual transactions ranging from $32.09 to $32.18.
- Following the transaction, Bellon directly owns 104,594 shares of Beam Therapeutics Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2023.
Sentiment
Score: 5
Explanation: This is a neutral event. The sale is related to tax obligations and executed under a pre-arranged trading plan, suggesting it's not indicative of the officer's sentiment about the company's future prospects.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations related to equity compensation. The existence of a pre-arranged 10b5-1 trading plan suggests the sale was planned in advance and not based on current market conditions or inside information.
Stakeholder Impact
- The sale of shares by an officer could be perceived negatively by some shareholders, although the pre-planned nature of the sale mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 03/31/2021 | Date of restricted stock unit grant. |
| 03/31/2022 | Date of restricted stock unit grant. |
| 03/31/2023 | Date of restricted stock unit grant. |
| 05/19/2023 | Date the Rule 10b5-1 trading plan was adopted. |
| 04/01/2024 | Date of the stock sale transaction. |
| 04/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.